Call for abstracts

The abstract portal is now closed!

Please note that the acceptance of your abstract does not include congress registration. We kindly ask for at least one author (the first or the presenting author) to register for the congress. Otherwise, the abstract will not be reviewed and will be dismissed by the scientific committee.



Do you have late-breaking science you would like to present at the 60th GTH meeting in Muenster? The 60th GTH meeting in Muenster welcomes the submission of late-breaking scientific abstracts. 

Depending on the number and quality of the “late-breaking science” abstracts, we might include a “late-breaking science” symposium on Saturday morning (20 February 2016) or accept your abstracts for poster presentation.

When is the late-breaking science abstract submission deadline?
The submission deadline is 30 November 2015.

How do I submit a late-breaking science abstract?
Please send two versions of your abstract, one including all data and a second one without information about authors (needed for blinded review) directly to 

Can I edit my abstract once it has been submitted?

Who will review these abstracts?
All abstracts are blindly reviewed by the congress presidents, members of
GTH2016 Advisory Boards, or members of the GTH Board.

When will I be notified of the results?
Notifications of the abstract selection will be sent in December 2015 via email to the corresponding authors of all abstracts, regardless of the outcome.


Guidelines to prepare your abstract

  • Abstract text is limited to 3,000 characters (incl. spaces)
  • Abstracts must be submitted in English
  • Please structure your abstract as follows:
    • Aims
    • Methods
    • Results
    • Conclusion
  • Tables can be used (included in the 3,000 characters)
  • Graphics and photos will not be accepted as well as literature references should not be included
  • All abstracts must contain original work that has not been published or presented on previous occasions
  • Please indicate your preferred type of presentation (oral or poster) and choose a topic from the drop-down list
  • Please check spelling and grammar carefully. All abstracts will be published as submitted
  • Use generic names. Commercial drug names may not be used

Presentation types

  • Oral presentation or poster
  • Oral presentation
  • Poster presentation

Submitted abstracts will be carefully reviewed. The scientific committee will decide on the acceptance of abstracts. Notifications of acceptance will be sent in writing. 


MCI Deutschland GmbH
MCI – Berlin Office
Markgrafenstrasse 56
10117 Berlin, Germany
Phone: +49 (0)30 20 45 9359
Fax: +49 (0)30 20 45 950